Conversely, 8/24 PALB2-associated breast cancers included in this study lacked bi-allelic PALB2 inactivation and 2/16 PALB2-associated breast cancers sequenced by WES lacked both bi-allelic PALB2 inactivation and genomic features of HRD. Here, PALB2 is linked to breast cancer.